Optimal Medical Therapy with or without PCI for Stable Coronary Disease
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In patients with stable coronary artery disease, it remains unclear whether an initial management strategy of percutaneous coronary intervention (PCI) with intensive pharmacologic therapy and lifestyle intervention (optimal medical therapy) is superior to optimal medical therapy alone in reducing the risk of cardiovascular events. METHODS: We conducted a randomized trial involving 2287 patients who had objective evidence of myocardial ischemia and significant coronary artery disease at 50 U.S. and Canadian centers. Between 1999 and 2004, we assigned 1149 patients to undergo PCI with optimal medical therapy (PCI group) and 1138 to receive optimal medical therapy alone (medical-therapy group). The primary outcome was death from any cause and nonfatal myocardial infarction during a follow-up period of 2.5 to 7.0 years (median, 4.6). RESULTS: There were 211 primary events in the PCI group and 202 events in the medical-therapy group. The 4.6-year cumulative primary-event rates were 19.0% in the PCI group and 18.5% in the medical-therapy group (hazard ratio for the PCI group, 1.05; 95% confidence interval [CI], 0.87 to 1.27; P=0.62). There were no significant differences between the PCI group and the medical-therapy group in the composite of death, myocardial infarction, and stroke (20.0% vs. 19.5%; hazard ratio, 1.05; 95% CI, 0.87 to 1.27; P=0.62); hospitalization for acute coronary syndrome (12.4% vs. 11.8%; hazard ratio, 1.07; 95% CI, 0.84 to 1.37; P=0.56); or myocardial infarction (13.2% vs. 12.3%; hazard ratio, 1.13; 95% CI, 0.89 to 1.43; P=0.33). CONCLUSIONS: As an initial management strategy in patients with stable coronary artery disease, PCI did not reduce the risk of death, myocardial infarction, or other major cardiovascular events when added to optimal medical therapy. (ClinicalTrials.gov number, NCT00007657 [ClinicalTrials.gov].).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The screening of asymptomatic individuals with high ASCVD risk is not recommended (Fig. 10.5), in part because these high-risk people should already be receiving intensive medical therapy-an approach that provides benefits similar to those of invasive revascularization (208,209).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [208]
In the citing paper
“The screening of asymptomatic individuals with high ASCVD risk is not recommended, in part because these high-risk people should already be receiving intensive medical therapy—an approach that provides benefits similar to those of invasive revascularization (197,198).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2026 (2026) · cites this paper as [197]
In the citing paper
“OMT with risk modification remains the foundation of management in patients with T2DM and CAD.263,264”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [264]
In the citing paper
“these high-risk patients should already be receiving intensive medical therapy -an approach that provides benefi t similar to invasive revascularization (172,173).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [172]
In the citing paper
“The screening of asymptomatic patients remains controversial, especially as intensive medical therapy indicated in diabetic patients at high risk for CVD has an increasing evidence base for providing equal outcomes to invasive revascularization, including in diabetic patients (222).”
From Standards of Medical Care in Diabetes—2009 (2009) · cites this paper as [222]
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
Writing Committee Members, Antman, E. M., Anbe, D. T., Armstrong, P. W., Bates, E. R., Green, L. A., Hand, M., Hochman, J. S., Krumholz, H. M., Kushner, F. G., et al. (2004) · Circulation · doi:10.1161/01.cir.0000134791.68010.fa · Cited by 8,356
Self-citationThe SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
(2001) · New England Journal of Medicine · doi:10.1056/nejmoa010746 · Cited by 6,470
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
Keeley, E. C., Boura, J. A., & Grines, C. L. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12113-7 · Cited by 4,361
Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease
LaRosa, J. C., Grundy, S. M., Waters, D. D., Shear, C., Barter, P., Fruchart, J.-C., Gotto, A. M., Greten, H., Kastelein, J. J. P., Shepherd, J., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050461 · Cited by 3,489
Research works printed but not linked: 2
- 1994, Lancet, 344, 1383
- 10.2307/2281868 · doi:10.2307/2281868 · Paper page
Cited by
Items 701–800 of 1,002
Percutaneous Coronary Revascularization
Serruys, P. W. J. C., Ono, M., Garg, S., Hara, H., Kawashima, H., Pompilio, G., Andreini, D., Holmes, D. R., Onuma, Y., & King, S. B. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.05.024 · Cited by 50
Non-invasive imaging as the cornerstone of cardiovascular precision medicine
Achenbach, S. S., Fuchs, F., Gonçalves, A., Kaiser‐Albers, C., Ali, Z. A., Bengel, F. M., Dimmeler, S., Fayad, Z. A., Mebazaa, A., Meder, B., et al. (2022) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeab287 · Cited by 49
Jun, E. J., Shin, E., Teoh, E.-V., Bhak, Y., Yuan, S. L., Chu, C. M., Garg, S., & Liew, H. B. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.821380 · Cited by 44
“A bailout glycoprotein IIb/IIIa receptor inhibitor strategy was allowed in cases of high thrombus burden (14).”
BackgroundPercutaneous Coronary Intervention for Chronic Stable Angina
Holmes, D. R., Gersh, B. J., Whitlow, P. L., King, S. B., & DOVE, J. T. (2008) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2007.10.001 · Cited by 44
Optimal revascularization for complex coronary artery disease
Iqbal, J., Serruys, P. W. J. C., & Taggart, D. P. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.138 · Cited by 46
Treatment of Atherosclerotic Intracranial Arterial Stenosis
Turan, T. N., Derdeyn, C. P., Fiorella, D., & Chimowitz, M. I. (2009) · Stroke · doi:10.1161/strokeaha.108.537589 · Cited by 43
Dowsley, T. F., Al-Mallah, M. H., Ananthasubramaniam, K., Dwivedi, G., McArdle, B., & Chow, B. J. W. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.10.022 · Cited by 46
Top 10 cardiovascular therapies and interventions for the next decade
Fuster, V. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.137 · Cited by 50
Morton, G., Schuster, A., Perera, D., & Nagel, E. C. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq256 · Cited by 44
Mehta, S. M., Depta, J. P., Novak, E. L., Patel, J. S., Patel, Y., Raymer, D. S., Facey, G., Zajarías, A., Lasala, J. M., Singh, J., et al. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002172 · Cited by 49
Coronary physiology assessment in the catheterization laboratory
Díez‐Delhoyo, F., Gutiérrez, E., Loughlin, G., y, R. S.-R., Vázquez-Álvarez, M. E., Sarnago‐Cebada, F., Angulo‐Llanos, R., Plasencia, A. C., Elı́zaga, J., & Díaz, F. F. A. (2015) · World Journal of Cardiology · doi:10.4330/wjc.v7.i9.525 · Cited by 44
Sen, H., Lam, M. K., Löwik, M. M., Danse, P. W., Jessurun, G. A. J., van Houwelingen, K. G., Anthonio, R. L., Gin, M. T. J., Hautvast, R. W. M., Louwerenburg, J. W., et al. (2015) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2015.01.033 · Cited by 47
Rozanski, A., Miller, R. J. H., Gransar, H., Han, D., Slomka, P. J., Dey, D., Hayes, S. W., Friedman, J. D., Thomson, L., & Berman, D. S. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.04.052 · Cited by 49
Self-citationIdentifying the Carotid ‘High Risk’ Plaque: Is it Still a Riddle Wrapped up in an Enigma?
Golledge, J., & Siew, D.-A. (2007) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2007.09.004 · Cited by 44
Multimodality imaging in ischaemic heart failure
Bax, J. J., Carli, M. F. D., Narula, J., & Delgado, V. (2019) · The Lancet · doi:10.1016/s0140-6736(18)33207-0 · Cited by 55
Association of Pretransplant Coronary Heart Disease Testing With Early Kidney Transplant Outcomes
Cheng, X. S., Liu, S., Han, J., Stedman, M. R., Baiocchi, M., Tan, J. C., Chertow, G. M., & Fearon, W. F. (2023) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2022.6069 · Cited by 46
Abubakar, M., Javed, I., Rasool, H. F., Raza, S., Basavaraju, D., Abdullah, R. M., Ahmed, F., Salim, S. S., Faraz, M. A., Hassan, K. M., et al. (2023) · Cureus · doi:10.7759/cureus.41311 · Cited by 60
“It is performed in stable CAD patients when medical therapy fails or if there is a significant disease affecting their quality of life [6,7].”
BackgroundSTICH3C: Rationale and Study Protocol
Fremes, S. E., Marquis‐Gravel, G., Gaudino, M. F. L., Jolicoeur, M. E., Bédard, S., Creber, R. M., Ruel, M., Vervoort, D., Wijeysundera, H. C., Farkouh, M. E., et al. (2023) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.122.012527 · Cited by 52
Self-citationIto, T., Tani, T., Fujita, H., & Ohte, N. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.07.115 · Cited by 43
Nijjer, S. S., Petraco, R., van de Hoef, T. P., Sen, S., van Lavieren, M. A., Foale, R. A., Meuwissen, M., Broyd, C., Pinto, M. E., Al-Lamee, R. K., et al. (2015) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.114.001715 · Cited by 43
Novel molecular targets for coronary angiogenesis and ischemic heart disease
Potz, B. A., Parulkar, A. B., Abid, R., Sodha, N. R., & Sellke, F. W. (2017) · Coronary Artery Disease · doi:10.1097/mca.0000000000000516 · Cited by 44
Alessio, A. M., Bindschadler, M., Busey, J. M., Shuman, W. P., Caldwell, J. H., & Branch, K. R. (2019) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.118.008323 · Cited by 43
Schumacher, S. P., Stuijfzand, W. J., de Winter, R. W., van Diemen, P. A., Bom, M. J., Everaars, H., Driessen, R. S., Kamperman, L., Kockx, M., Hagen, B. S. H., et al. (2021) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2021.04.044 · Cited by 51
Acharjee, S., Teo, K. K., Jacobs, A. K., Hartigan, P. M., Barn, K., Gosselin, G., Tanguay, J., Maron, D. J., Kostuk, W. J., CHAITMAN, B. R., et al. (2015) · American Heart Journal · doi:10.1016/j.ahj.2015.07.020 · Cited by 45
Self-citationThe links between complex coronary disease, cerebrovascular disease, and degenerative brain disease
Kovacic, J. C., Castellano, J. M., & Fuster, V. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06482.x · Cited by 48
“strategy for the majority of patients with stable CAD Boden et al.(47)”
BackgroundAldea, G. S., Mokadam, N. A., Melford, R., Stewart, D. K., Maynard, C. C., Reisman, M., & Goss, R. (2009) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2009.03.067 · Cited by 43
Noninvasive Diagnosis and Prognosis Assessment in Chronic Coronary Artery Disease
Gibbons, R. J. (2008) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.108.823286 · Cited by 43
Paradigm Shift to Functional Angioplasty
Park, S., Ahn, J., & Kang, S. (2011) · Circulation · doi:10.1161/circulationaha.110.012344 · Cited by 42
Carrasco‐Chinchilla, F., Muñoz-García, A. J., Domínguez-Franco, A. J., Millán-Vázquez, G., Guerrero-Molina, A., Ortiz-García, C., Enguix-Armada, A., Alonso-Briales, J. H., Hernández-García, J. M., de Teresa–Galván, E., et al. (2013) · Heart · doi:10.1136/heartjnl-2013-304172 · Cited by 42
Coronary Computed Tomography Angiography in Prediction of First Coronary Events
Bergström, G. M. L., Engström, G., Björnson, E., Adiels, M., Andersson, J. S. O., Andersson, T., Carlhäll, C., Cederlund, K., Erlinge, D., Fagman, E., et al. (2025) · JAMA · doi:10.1001/jama.2025.21077 · Cited by 49
The Diagnosis and Treatment of Pulmonary Embolism
Prasad, V. K., Rho, J., & Cifu, A. S. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2012.195 · Cited by 43
“The Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation trial in part shattered this paradigm by showing that omitting stents is safe for many patients with stable disease.(21) Now future trials are desperately needed to examine still untested areas of revascularization.”
MethodNallamothu, B. K., & Krumholz, H. M. (2010) · JAMA · doi:10.1001/jama.2010.1509 · Cited by 42
Phillips, L. M., Hachamovitch, R., Berman, D. S., Iskandrian, A. E., Min, J. K., Picard, M. H., Kwong, R. Y. K., Friedrich, M. G., Scherrer‐Crosbie, M., Hayes, S. W., et al. (2013) · Journal of Nuclear Cardiology · doi:10.1007/s12350-013-9773-4 · Cited by 42
“However, eligibility for recent negative trials in SIHD mandated only minimal standards for ischemia.(4,5) The current review will highlight the available evidence regarding the potential role of ischemia in guiding decisions for revascularization in SIHD.”
InfluentialSelf-citationGarg, P., Galper, B. Z., Cohen, D. J., Yeh, R. W., & Mauri, L. (2014) · American Heart Journal · doi:10.1016/j.ahj.2014.11.002 · Cited by 43
Gašević, D., Khan, N. A., Qian, H., Karim, S. S., Simkus, G. J., Quan, H., Mackay, M., O’Neill, B. J., & Ayyobi, A. F. (2013) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-13-121 · Cited by 47
Yao, H.-M., Wan, Y.-D., Zhang, X., Shen, D., Zhang, J., Li, L., Zhao, L., & Sun, T. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-004892 · Cited by 42
van Waardhuizen, C. N., Khanji, M. Y., Genders, T. S. S., Ferket, B. S., Fleischmann, K. E., Hunink, M. G. M., & Petersen, S. E. (2016) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcw029 · Cited by 47
“trial, a lack of clinical benefit for death or MI when PCI of angiographically significant lesions was added to OMT in stable CAD patients was shown (22).”
Driessen, R. S., de Waard, G. A., Stuijfzand, W. J., Raijmakers, P. G. H. M., Danad, I., Bom, M. J., Min, J. K., Leipsic, J. A., Ahmadi, A. A., van de Ven, P. M., et al. (2019) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2019.06.013 · Cited by 42
Chuang, A., Nguyen, M. T., Kung, W., Lehman, S. J., & Chew, D. P. (2020) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm.2020.02.17 · Cited by 44
“…two randomised trials have compared initial optimal medical therapy (OMT) to initial invasive therapy in the general population (Al-Lamee et al., 2018; Boden et al., 2007), the only large randomised trial to-date specific to CKD patients is the recently completed ISCHEMIA-CKD trial (NCT01985360).”
BackgroundRationale, Design, and Implementation of Intensive Risk Factor Treatment in the CREST2 Trial
Turan, T. N., Voeks, J. H., Chimowitz, M. I., Roldan, A., LeMatty, T., Haley, W. E., Lopes-Virella, M. F., Chaturvedi, S., Jones, M. R., Heck, D. V., et al. (2020) · Stroke · doi:10.1161/strokeaha.120.030730 · Cited by 43
Kawase, Y., Matsuo, H., Kuramitsu, S., Shiono, Y., Akasaka, T., Tanaka, N., Amano, T., Kozuma, K., Nakamura, M., Yokoi, H., et al. (2022) · Cardiovascular Intervention and Therapeutics · doi:10.1007/s12928-022-00863-1 · Cited by 43
“The Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial [1], which showed no advantage of angiography-guided PCIs over optimal medical therapy, provided the opportunity to seriously consider the application of PCIs.”
BackgroundMethodPercutaneous Revascularization for Stable Coronary Artery Disease
Hilliard, A. A., From, A. M., Lennon, R. J., Singh, M., Lerman, A., Gersh, B. J., Holmes, D. R., Rihal, C. S., & Prasad, A. (2010) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2009.11.013 · Cited by 42
Ranolazine: A Review of its Use in Chronic Stable Angina Pectoris
Keating, G. M. (2008) · Drugs · doi:10.2165/0003495-200868170-00006 · Cited by 43
“[4] stable coronary disease who received optimal medical therapy (with or without percutaneous coroThe recommended initial ranolazine ER dosage nary intervention) still had angina after 5 years.[69] is 375 mg twice daily.”
BackgroundCleland, J. G. F., Coletta, A. P., & Clark, A. L. (2007) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2007.04.004 · Cited by 43
“The clinical outcomes utilizing revascularisation and aggressive drug evaluation (COURAGE) trial [published in full [14]]”
MethodA plant-based diet and coronary artery disease: a mandate for effective therapy.
Esselstyn, C. B. (2017) · PubMed Central · doi:10.11909/j.issn.1671-5411.2017.05.004 · Cited by 56
Généreux, P., Campos, C. M., Yadav, M., Palmerini, T., Caixeta, A. M., Xu, K., Francese, D. P., Dangas, G., Mehran, R., Leon, M. B., et al. (2015) · EuroIntervention · doi:10.4244/eijy14m10_05 · Cited by 41
Lee, S., Lee, J., Park, D., Kim, Y., Yun, S., Kim, W., Suh, J., Cho, Y. H., Lee, N., Kang, S., et al. (2011) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.23019 · Cited by 41
“Optimal medical therapy is important [30], and most of our patients in both groups received multiple medications to improve clinical outcomes, including aspirin, statin, angiotensin-converting enzyme or angiotensin receptor blocker, and betablocker.”
BackgroundMethodGaemperli, O., Kaufmann, P. A., & Alkadhi, H. (2014) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-013-2566-9 · Cited by 43
“Large randomized clinical trials have failed to demonstrate superiority of revascularization over modern medical treatment in terms of long-term cardiovascular events if patients are not stratified by prior ischaemia testing [12, 13].”
BackgroundLadwiniec, A., Allgar, V. L., Thackray, S. D. R., Alamgir, F., & Hoye, A. (2015) · Heart · doi:10.1136/heartjnl-2015-308181 · Cited by 41
Managing Coronary Artery Disease in the Cancer Patient
Krone, R. J. (2010) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2010.06.004 · Cited by 43
Erné, P., Schoenenberger, A. W., Züber, M., BURCKHARDT, D., Kiowski, W., Dubach, P., Resink, T. J., & Pfisterer, M. E. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm273 · Cited by 41
Heydari, B., Juan, Y., Liu, H., Abbasi, S. A., Shah, R. V., Blankstein, R., Steigner, M. L., Jerosch‐Herold, M., & Kwong, R. Y. K. (2016) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.115.004136 · Cited by 42
Coronary artery disease and diabetes mellitus
Al-Nozha, M. M., Ismail, H. M., & Nozha, O. M. A. (2016) · Journal of Taibah University Medical Sciences · doi:10.1016/j.jtumed.2016.03.005 · Cited by 62
Cademartiri, F., Seitun, S., Clemente, A., Grutta, L. L., Toia, P., Runza, G., Midiri, M., & Maffei, E. (2017) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt.2017.03.22 · Cited by 41
“Furthermore, a large randomized controlled trial, the COURAGE trial, have demonstrated that PCI based solely on standard visual approach offers no benefits over optimal medical therapy in reducing mortality, myocardial infarction, or other major cardiovascular events (9).”
BackgroundZampella, E., Acampa, W., Assante, R., Gaudieri, V., Nappi, C., Mannarino, T., Mainolfi, C. G., Arumugam, P., Petretta, M., & Cuocolo, A. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04534-x · Cited by 41
Daubert, M. A., Tailor, T. D., James, O. G., Shaw, L. J., Douglas, P. S., & Koweek, L. (2020) · British Journal of Radiology · doi:10.1259/bjr.20200780 · Cited by 50
Self-citationThe case for intervention bias in the practice of medicine.
Foy, A., & Filippone, E. J. (2013) · Europe PMC (PubMed Central) · Cited by 43
Nuclear cardiology will remain the “gatekeeper” over CT angiography
Hachamovitch, R., & Carli, M. F. D. (2007) · Journal of Nuclear Cardiology · doi:10.1016/j.nuclcard.2007.06.118 · Cited by 41
PCI for Stable Coronary Disease
Katritsis, D. G., & Ioannidis, J. P. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmc071317 · Cited by 41
Bloom, J. E., Vogrin, S., Reid, C. M., Ajani, A. E., Clark, D., Freeman, M., Hiew, C., Brennan, A., Dinh, D., Williams‐Spence, J., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae672 · Cited by 48
Henriksson, M., Palmer, S., Chen, R., Damant, J., Fitzpatrick, N. K., Abrams, K. R., Hingorani, A. D., Stenestrand, U., Janzon, M., Feder, G. S., et al. (2010) · BMJ · doi:10.1136/bmj.b5606 · Cited by 47
Shah, S. A., Shapiro, R. J., Mehta, R., & Snyder, J. A. (2010) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.30.7.639 · Cited by 40
Informed Decision Making for Percutaneous Coronary Intervention for Stable Coronary Disease
Rothberg, M. B., Sivalingam, S. K., Kleppel, R., Schweiger, M. J., Hu, B., & Sepucha, K. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.1657 · Cited by 40
“In response, they recommended that physicians (1) ensure patients are aware of the benefits and risks of PCI and (2) educate the public that PCI is not appropriate in all cases.”
BackgroundFinancial Stress and Outcomes after Acute Myocardial Infarction
Shah, S. J., Krumholz, H. M., Reid, K. J., Rathore, S. S., Mandawat, A., Spertus, J. A., & Ross, J. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047420 · Cited by 39
“Moreover, while the general health differences between patients reporting severe financial stress and those reporting no financial stress were modest, not major, differences in physical and mental function, the difference in SAQ scores was equal, or greater, in magnitude than the benefits of percutaneous coronary inte…”
ResultSelf-citationSweitzer, B. J. (2008) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0b013e3283126cf3 · Cited by 40
Mouden, M., Ottervanger, J. P., Knollema, S., Timmer, J. R., Reiffers, S., Oostdijk, A. H. J., de Boer, M., & Jager, P. L. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-013-2630-5 · Cited by 39
“Despite this uncertainty, FFR measurement is considered by many cardiologists to be the most accurate test for depicting ischaemia, while also providing additional prognostic information [16, 28–31].”
BackgroundUse of the HEART Pathway with high sensitivity cardiac troponins: A secondary analysis
Mahler, S. A., Stopyra, J. P., Apple, F. S., Riley, R. F., Russell, G. B., Hiestand, B. C., Hoekstra, J. W., Lefebvre, C. W., Nicks, B. A., Cline, D. M., et al. (2017) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2017.01.003 · Cited by 41
Boden, W. E., Caterina, R. D., Kaski, J. C., Merz, C. N. B., Berry, C., Marzilli, M., Pepine, C. J., Barbato, E., Stefanini, G. G., Prescott, E., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae278 · Cited by 48
Self-citationYadav, A., Singh, S., Singh, K., & Pai, P. (2014) · International Journal of Yoga · doi:10.4103/0973-6131.146067 · Cited by 52
“[22] Ornish et al. showed short term and long term benefits of lifestyle changes (without using cholesterol lowering drugs) on coronary lesions and clinical manifestations of CAD.”
BackgroundInfluentialPark, K. W., Jeon, K., Kang, S.-H., Oh, I., Cho, H., Lee, H., Kang, H., Park, S. K., Koo, B., Oh, B., et al. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.07.012 · Cited by 39
Généreux, P., Campos, C. M., Farooq, V., Bourantas, C. V., Mohr, F. W., Colombo, A., Morel, M.-A., Feldman, T. E., Holmes, D. R., Mack, M. J., et al. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.03.056 · Cited by 39
Schachner, T., Bonaros, N. E., Wiedemann, D., Lehr, E. J., Weidinger, F., Feuchtner, G. M., Zimrin, D. A., & Bonatti, J. O. (2011) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2010.10.072 · Cited by 39
Hospital Percutaneous Coronary Intervention Appropriateness and In-Hospital Procedural Outcomes
Bradley, S. M., Chan, P. S., Spertus, J. A., Kennedy, K. F., Douglas, P. S., Patel, M. R., Anderson, H. V., Ting, H. H., Rumsfeld, J. S., & Nallamothu, B. K. (2012) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.112.966044 · Cited by 39
Self-citationKruse, B. C., & Vassar, M. B. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.10.007 · Cited by 39
Stable Coronary Artery Disease: Treatment.
Braun, M. M., Stevens, W. A., & Barstow, C. H. (2018) · PubMed · Cited by 61
Maroules, C. D., Rajiah, P. S., Bhasin, M., & Abbara, S. (2018) · Journal of Thoracic Imaging · doi:10.1097/rti.0000000000000357 · Cited by 41
The Effect of Age on Clinical Outcomes and Health Status
Chung, S., Hlatky, M. A., Faxon, D. P., Ramanathan, K. B., Adler, D. S., Mooradian, A. D., Rihal, C. S., Stone, R. A., Bromberger, J. T., Kelsey, S. F., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.05.020 · Cited by 39
“approach was shown to achieve a similar survival advantage for older and younger patients (2,3).”
Differentiation of severe coronary artery calcification in the Multi-Ethnic Study of Atherosclerosis
Coylewright, M. J., Rice, K. M., Budoff, M. J., Blumenthal, R. S., Greenland, P., Kronmal, R. A., Barr, R. G., Burke, G. L., Tracy, R. P., & Post, W. S. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.08.038 · Cited by 39
Squires, R. W., Montero-Gómez, A., Allison, T. G., & Thomas, R. J. (2008) · Journal of Cardiopulmonary Rehabilitation and Prevention · doi:10.1097/01.hcr.0000320068.35728.12 · Cited by 43
ALDH2 polymorphism and myocardial infarction: From alcohol metabolism to redox regulation
Lamb, R. J., Griffiths, K., Lip, G. Y. H., Sorokin, V. A., Frenneaux, M. P., Feelisch, M., & Madhani, M. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108666 · Cited by 41
Andrade, N. S., Flynn, J. P., & Bartanusz, V. (2013) · The Spine Journal · doi:10.1016/j.spinee.2013.06.071 · Cited by 39
“It has also been noted that guidelines based on clinical research findings do not necessarily translate into practice [72], especially when such guidelines suggest the curtailment of procedures [73,74].”
BackgroundMancini, G. B. J., Bates, E., Maron, D. J., Hartigan, P. M., Dada, M. R., Gosselin, G., Kostuk, W. J., Sedlis, S. P., Shaw, L. J., Berman, D. S., et al. (2009) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.108.830091 · Cited by 38
Self-citationNovel bioabsorbable polymer and polymer-free metallic drug-eluting stents
Nogic, J., McCormick, L. M., Francis, R., Nerlekar, N., Jaworski, C., West, N. E. J., & Brown, A. J. (2018) · Journal of Cardiology · doi:10.1016/j.jjcc.2017.12.007 · Cited by 38
Martin, G., Patel, N. C., Grant, Y., Jenkins, M. P., Gibbs, R. G. J., & Bicknell, C. D. (2018) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2017.12.063 · Cited by 43
Soares, A., Boden, W. E., Hueb, W. A., Brooks, M. M., Vlachos, H., O’Fee, K., Hardi, A., & Brown, D. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.019114 · Cited by 38
“12 Second, not all participants in MASS II, 18 COURAGE, 19 BARI 2D, 20 and STICH 21 underwent stress testing.”
Self-citationImpact of Percutaneous Coronary Intervention on Outcomes in Patients With Heart Failure
Parikh, P. B., Bhatt, D. L., Bhasin, V., Anker, S. D., Skopicki, H. A., Claessen, B. E. P. M., Fonarow, G. C., Hernandez, A. F., Mehran, R., Petrie, M. C., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.03.310 · Cited by 52
Lin, G. A., Dudley, R. A., & Redberg, R. F. (2008) · Journal of General Internal Medicine · doi:10.1007/s11606-008-0706-x · Cited by 38
Spertus, J. A., Maron, D. J., Cohen, D. J., Kolm, P., Hartigan, P. M., Weintraub, W. S., Berman, D. S., Teo, K. K., Shaw, L. J., Sedlis, S. P., et al. (2013) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.113.000139 · Cited by 37
Self-citationManagement of stable angina: A commentary on the European Society of Cardiology guidelines
Ambrosio, G., Mugelli, A., Lopez-Sendon, J. L., Tamargo, J. L., & Camm, A. J. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316648475 · Cited by 45
Galonska, M., Ducke, F., Kertesz, T., Meyer, R., Guski, H., & Knollmann, F. D. (2008) · Academic Radiology · doi:10.1016/j.acra.2007.09.007 · Cited by 38
Patient Selection for Elective Revascularization to Reduce Myocardial Infarction and Mortality
Gould, K. L., Johnson, N. P., Kaul, S., Kirkeeide, R. L., Mintz, G. S., Rentrop, K. P., Sdringola, S. M., Virmani, R., & Narula, J. (2015) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.114.003099 · Cited by 37
Nonischemic or Dual Cardiomyopathy in Patients With Coronary Artery Disease
Bawaskar, P. H., Thomas, N., Ismail, K., Guo, Y. Y., Chhikara, S., Athwal, P. S. S., Ranum, A. N., Jadhav, A., Mendez, A. H., Nadkarni, I., et al. (2023) · Circulation · doi:10.1161/circulationaha.123.067032 · Cited by 43
Thalji, N. M., Suri, R. M., Daly, R. C., Dearani, J. A., Burkhart, H. M., Park, S. J., Greason, K. L., Joyce, L. D., Stulak, J. M., Huebner, M., et al. (2013) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2013.06.046 · Cited by 42
“Peripheral vascular disease 362 (7) 16 (2) 346 (7) <.”
Molecular imaging of plaque vulnerability
Tavakoli, S., Vashist, A., & Sadeghi, M. M. (2014) · Journal of Nuclear Cardiology · doi:10.1007/s12350-014-9959-4 · Cited by 37
Biondi‐Zoccai, G., Sheiban, I., Romagnoli, E., Servi, S. D., Tamburino, C., Colombo, A., Burzotta, F., Presbitero, P., Bolognese, L., Paloscia, L., et al. (2011) · Clinical Research in Cardiology · doi:10.1007/s00392-011-0336-x · Cited by 37
Turrini, F., Scarlini, S., Mannucci, C., Messora, R., Giovanardi, P., Magnavacchi, P., Cappelli, C., Evandri, V., Zanasi, A., Romano, S., et al. (2015) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2015.05.006 · Cited by 38
“On the other hand, COURAGE [24] and the subsequent BARI 2D [25] studies, represent the landmark trials in the field of stable CAD treatment.”
MethodYANG, Z. K., Shen, Y. H., Shen, W. F., Pu, L. J., Meng, H., Zhang, R., Zhang, Q., Chen, Q., Caterina, R. D., & Lu, L. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.06.003 · Cited by 34
Stopyra, J. P., Miller, C. D., Hiestand, B. C., Lefebvre, C. W., Nicks, B. A., Cline, D. M., Askew, K. L., Riley, R. F., Russell, G. B., Hoekstra, J. W., et al. (2015) · Critical Pathways in Cardiology A Journal of Evidence-Based Medicine · doi:10.1097/hpc.0000000000000059 · Cited by 37
Progenitor Cells for Arterial Repair: Incremental Advancements towards Therapeutic Reality
Simard, T., Jung, R. G., Motazedian, P., Santo, P. D., Ramirez, F. D., Russo, J. J., Labinaz, A., Yousef, A., Anantharam, B., Pourdjabbar, A., et al. (2017) · Stem Cells International · doi:10.1155/2017/8270498 · Cited by 40
Guo, L., Zhong, L., Chen, K., Wu, J., & Huang, R.-C. (2018) · Hellenic Journal of Cardiology · doi:10.1016/j.hjc.2018.03.005 · Cited by 37
Metadata
- Authors
- Boden, W. E., O'Rourke, R. A., Teo, K. K., Hartigan, P. M., Maron, D. J., Kostuk, W. J., Knudtson, M., Dada, M., Casperson, P., Harris, C. L., Chaitman, B. R., Shaw, L., Gosselin, G., Nawaz, S., Title, L. M., Gau, G., Blaustein, A. S., Booth, D. C., Bates, E. R., Spertus, J. A., Berman, D. S., Mancini, G. B. J., & Weintraub, W. S.
- Affiliations
- VA Western New York Healthcare System (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-04-12
- Volume
- 356
- Issue
- 15
- Pages
- 1503-1516
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2160414137
- Cited by
- 4,699
- References
- 49
- Citations by year
- 2026: 111 · 2025: 142 · 2024: 150 · 2023: 166 · 2022: 197 · 2021: 255 · 2020: 282 · 2019: 202 · 2018: 227 · 2017: 211 · 2016: 276 · 2015: 263 · 2014: 295 · 2013: 309 · 2012: 322
- FWCI
- 315.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Keywords
- optimal medical therapy, percutaneous coronary intervention, stable coronary artery disease, myocardial ischemia, cardiovascular events, myocardial infarction, mortality, lifestyle intervention, coronary artery disease
- MeSH terms
- Adrenergic beta-Antagonists, Aged, Angina Pectoris, Angiotensin-Converting Enzyme Inhibitors, Anticholesteremic Agents, Antihypertensive Agents, Combined Modality Therapy, Coronary Disease, Drug Therapy, Combination, Female, Humans, Male, Middle Aged, Myocardial Infarction, Platelet Aggregation Inhibitors, Risk Factors, Angioplasty, Balloon, Coronary, Proportional Hazards Models, Stroke, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.